spironolactone has been researched along with 8-hydroxy-2'-deoxyguanosine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Koda, M; Matono, T; Murawaki, Y; Sugihara, T; Tokunaga, S; Ueki, M | 1 |
Ando, K; Fujita, M; Fujita, T; Kawarazaki, H; Matsui, H; Nagae, A | 1 |
Amann, K; Brand, S; Mandel, P; Schupp, N; Zimnol, A | 1 |
Hayashi, S; Ishizuka, A; Iwashima, Y; Kawano, Y; Kishida, M; Nakamura, S; Ohta, Y; Yoshihara, F | 1 |
Barrera-Chimal, J; Bobadilla, NA; Espinoza, R; González, N; González-Bobadilla, Y; Juárez, H; Marino, LA; Morales-Buenrostro, LE; Ortega-Trejo, JA; Pérez-Villalva, R; Zamora-Mejía, FM | 1 |
2 trial(s) available for spironolactone and 8-hydroxy-2'-deoxyguanosine
Article | Year |
---|---|
Effects of a selective aldosterone blocker and thiazide-type diuretic on blood pressure and organ damage in hypertensive patients.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Blood Pressure; Blood Pressure Determination; Calcium Channel Blockers; Deoxyguanosine; Diuretics; Eplerenone; Female; Glomerular Filtration Rate; Humans; Hypertension; Indapamide; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Potassium; Pulse Wave Analysis; Spironolactone; Treatment Outcome; Uric Acid | 2015 |
Spironolactone reduces oxidative stress in living donor kidney transplantation: a randomized controlled trial.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Antioxidants; Biomarkers; Double-Blind Method; Female; HSP72 Heat-Shock Proteins; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Lipocalin-2; Living Donors; Male; Mexico; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Pilot Projects; Spironolactone; Time Factors; Treatment Outcome; Young Adult | 2019 |
3 other study(ies) available for spironolactone and 8-hydroxy-2'-deoxyguanosine
Article | Year |
---|---|
The effects of the selective mineralocorticoid receptor antagonist eplerenone on hepatic fibrosis induced by bile duct ligation in rat.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldehydes; Animals; Bile Ducts; Deoxyguanosine; Eplerenone; Gene Expression Regulation; Hydroxyproline; Immunohistochemistry; Ligation; Lipid Peroxidation; Liver Cirrhosis; Male; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Rats; Rats, Wistar; RNA, Messenger; Spironolactone | 2010 |
Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Cyclic N-Oxides; Deoxyguanosine; Eplerenone; Hydralazine; Hypertension; Kidney; Male; Mineralocorticoid Receptor Antagonists; Rats; Rats, Inbred Dahl; Receptors, Mineralocorticoid; Renal Insufficiency; Sodium Chloride, Dietary; Spin Labels; Spironolactone | 2010 |
Oxidative DNA damage in kidneys and heart of hypertensive mice is prevented by blocking angiotensin II and aldosterone receptors.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cyclic N-Oxides; Deoxyguanosine; DNA Damage; DNA Repair; Enzyme Activation; Eplerenone; Guanosine; Heart; Hypertension; Kidney; Male; Mice; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System; Spin Labels; Spironolactone; Tetrazoles | 2014 |